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A 50-year-old Chinese lady presented with subacute onset of dyspnoea, bilateral infiltrates on chest X-ray and 
type I respiratory failure. There were minor symptoms of arthralgia and myalgia. Subsequent investigations 
confirmed that she had organizing pneumonia, polymyositis and serum anti-Jo-l antibody. Treatment with 
corticosteroids resulted in prompt improvement of the respiratory condition and myositis. 
Introduction 
The anti-Jo-l antibody (anti threonyl-tRNA syn- 
thetase) is found in about 25% of patients with adult 
polymyositis (1). It is associated with interstitial lung 
disease, usually fibrosing alveolitis (2,3). The associa- 
tion of polymyositis and organizing pneumonia 
(bronchiolitis obliterans organizing pneumonia, 
BOOP), have been well reported (4), but the associa- 
tion of polymyositis, anti-Jo-l antibody and organiz- 
ing pneumonia has rarely been described. We report 
a patient who presented with subacute respiratory 
failure due to organizing pneumonia, in whom inves- 
tigations confirmed inflammatory myositis and the 
presence of serum anti-Jo-l antibody. 
Case Report 
A 50-year-old Chinese female, a non-smoker with 
unremarkable past medical history, presented with 
progressive dyspnoea over 4 days. About 3 weeks 
prior to presentation, she noted mild polyarthralgia 
of both hands, elbows and shoulders. She then devel- 
oped fever and unproductive cough for 2 weeks, and 
chest X-ray showed a small right pleural effusion 
with bilateral basal infiltrates. She was given erythro- 
mycin for 1 week with no improvement. 
On examination at admission, the patient was 
tachypnoeic at rest. There was central cyanosis, no 
pallor, lymphadenopathy, clubbing, muscle weakness 
or skin rash. The fingers were slightly swollen but 
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there was no definite evidence of synovitis. Tempera- 
ture was elevated at 38°C. On auscultation of the 
chest, there were bilateral mid and late inspiratory 
crepitations at both lung bases. Other systems were 
normal. 
Chest radiograph on admission showed bilateral 
lower lobe infiltrates, worse on the right side, and 
they had progressed slightly compared with 2 weeks 
previous. Blood gases showed type I respiratory 
failure with PaO, of 7.6 kPa, PaCO, of 4.2 kPa, 
pH 7.4 in room air. The blood counts were normal 
except for a slightly elevated white cell count of 
12.4 x lo9 1~ ‘, with 81% neutrophils. The erythro- 
cyte sedimentation rate was 55 mm in the first 
hour. Renal and liver function tests were normal. 
After septic work-up, the patient was treated empiri- 
cally with doxycycline, sulbactamlampicillin and 
ceftazidime. 
She deteriorated with worsening hypoxaemia. 
Symptoms of myalgia of the upper arms developed, 
and the serum creatine kinase (CK) performed on 
the third day of hospitalization was elevated at 
889 IU l- ’ with normal MB fraction. This rose to 
2190 IU I- ’ over the next few days. The septic 
work-up, anti-nuclear factor, rheumatoid factor, anti 
Sm, Ro, La, anti-ribonuclear protein, and anti- 
neutrophil cytoplasmic antibody were all negative. 
In view of the elevated CK, the diagnosis of poly- 
myositis with interstitial lung disease was considered, 
and serum was sent to be tested for anti-Jo-l 
antibody. 
Fiberoptic bronchoscopy showed no endo- 
bronchial lesion. Bronchoalveolar lavage was 
negative for micro-organisms. Transbronchial lung 
biopsy showed non-specific features of a mixed poly- 
morphonuclear and lymphocytic inflammatory cell 
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Plate I HRCT of the lower lungs shows subpleurally- 
located consolidation with air-bronchogram effect, and 
diffuse lower lobe ‘ground-glass’ opacification which are 
well demarcated from the relatively normal lung located 
anteriorly. 
infiltration of the interstitium with an abundance of 
foamy macrophages. A muscle biopsy of the left 
deltoid was performed but preliminary findings were 
non-contributory. 
High resolution computed tomography (HRCT) of 
the thorax showed bilateral air-space consolidation 
with air-bronchograms, located predominantly sub- 
pleurally over both lower lobes. There was also 
increased ‘ground-glass’ opacification more diffusely 
distributed in the lower lobes. The margin between 
normal lung and the abnormal parenchymal zones 
were well demarcated (Plate 1). 
The patient continued to deteriorate in her 
ventilatory status. She also developed deranged liver 
function, and hyponatraemia due to inappropriate 
antidiuretic hormone secretion. On the tenth day 
after admission, methylprednisolone 80 mg day - ’ 
was started on the presumptive diagnosis of rapidly 
progressing fibrosing alveolitis or organizing pneu- 
monia. Three days later, she underwent a mini- 
thoracotomy and wedge biopsy, which showed 
typical changes of organizing pneumonia, with 
fibroblastic tissue forming myxoid plugs in the bron- 
chioles and alveolar ducts, with minimal interstitial 
fibrosis. Stains and cultures for micro-organisms 
were negative. 
The muscle biopsy, on further sectioning, showed 
dense perivascular lymphocytic infiltration around a 
capillary, with atrophy of the type II fibres and no 
evidence of vasculitis. The findings were consistent 
with an inflammatory myopathy. The analysis of 
serum for anti-Jo-l antibody showed a positive 
result. 
The patient improved significantly about 5 days 
after initiation of steroids with gradual resolution of 
the chest radiographic changes over the following 2 
weeks. Azathioprine was added while steroids were 
tapered. Creatine kinase level normalized at the ninth 
week. The patient was asymptomatic with regards to 
her respiratory and muscle status, but developed 
roughening and cracking of the skin of both hands, 
typical of ‘mechanic’s hands’, as described in the 
anti-Jo-l syndrome, which required frequent 
application of topical steroid. 
Discussion 
The association of polymyositis/dermatomyositis 
and interstitial lung disease has been well docu- 
mented since its original description in 1956. Most 
reports refer to the lung involvement as ‘pulmonary 
fibrosis’. In the few studies that addressed the pul- 
monary pathohistological findings, the interstitial 
lung disease in polymyositisldermatomyositis in- 
cluded fibrosing alveolitis, organizing pneumonia, 
diffuse alveolar damage and cellular interstitial pneu- 
monitis (4). Hence the association of organizing 
pneumonia and polymyositis is not new. However, 
the anti-Jo-l antibody status in most of these cases 
was not known. Anti-Jo-l antibody is an auto- 
antibody (anti ENA) directed at the cellular enzyme 
histidyl-tRNA synthetase. It is found in lo-50% of 
patients with myositis but not in other myopathies 
and rarely in other connective tissue diseases (l-3,5). 
The finding of anti-Jo-l antibody is associated with 
the presence of interstitial lung disease, usually 
fibrosing alveolitis (UIP), and arthritis (l-3,5). Or- 
ganizing pneumonia as the form of lung involvement 
in the anti-Jo-l myositis has only been rarely reported 
(6). The presence of anti-Jo-l antibody and inter- 
stitial lung disease may even precede the onset of 
polymyositis (2,6). It is reasonable to postulate that 
fibrosing alveolitis and organizing pneumonia are 
different manifestations of an underlying immuno- 
logical disease. While its role in the pathogenesis is 
unclear, it seems unlikely that the anti-Jo-l antibody 
is directly responsible for causing disease (5). 
In our patient, pulmonary symptoms dominated 
the clinical picture, with muscle and joint symptoms 
being minor complaints. Myalgia was not severe and 
muscle weakness was not clinically apparent, and 
could have been further masked by incapacitation 
from respiratory failure. The CK was only moder- 
ately elevated. These features are unusual for 
anti-Jo-l syndrome in which the myositis is charac- 
teristically severe, and led to difficulty in differentiat- 
ing infective pneumonia with rhabdomyolysis from 
non-infective interstitial lung disease associated 
with polymyositis. The lung HRCT findings were 
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interesting in that areas of dense consolidation with 
air-bronchograms as well as ground-glass opacifica- 
tion, and clear demarcation of normal and abnormal 
lung tissue were demonstrated. These features distin- 
guish organizing pneumonia from the better known 
CT appearance of ground-glass and honeycombing 
typical of fibrosing alveolitis (7), but they can also 
simulate infective pneumonia. Although a diagnosis 
of organizing pneumonia was Subsequently estab- 
lished on lung biopsy, histological features cannot 
usually differentiate ‘cryptogenic’ organizing pneu- 
monia (COP) and organizing pneumonia associated 
with different disease cqnditions. The presenting 
symptoms and the early course of our patient were 
quite compatible with that of COP (8,9). Hence, this 
case highlights the importance of a careful search for 
associated connective tissue disorder, including poly- 
myositis or dermatomyositis, in patients presenting 
with ‘atypical pneumonia’. 
In polymyositis, those presenting with organizing 
pneumonia have a better prognosis than those 
presenting with fibrosing alveolitis (4), while poly- 
myositis associated organizing pneumonia probably 
carries a worse prognosis than cryptogenic organiz- 
ing pneumonia (4,9), and the presence of serum 
anti-synthetase antibody is further associated with 
lesser response to steroids, flair of disease when 
steroid dose is tapered and lower survival (1,5,9). 
These distinctions would therefore carry therapeutic 
implications - while cryptogenic organizing pneumo- 
nia could well be treated with corticosteroids alone 
(8,9), those patients with organizing pneumonia and 
polymyositis, in particular anti-Jo-l positive, may 
require additional immunosuppressive therapy (1,5). 
The CK levels and anti-Jo-l antibody should there- 
fore be simple additions to the usual investigations 
for ‘idiopathic’ interstitial lung diseases since the 
muscle symptoms may be overshadowed by respira- 
tory manifestations, and be further complicated if 
steroids have been given for treatment. 
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